Oleg Tyszkiwski CENTRUM GASTROLOGICZNE GORCZYN OLEG TYSZKIWSKI
- Address
- ul. Albanska 12/1, 60-123 Poznan, Poland
Digestive System Diseases
The Oleg Tyszkiwski Centrum Gastro‑Logiczne Gorczyn specializes in research on ulcerative colitis, testing a novel biologic agent to induce clinical remission and to evaluate its long‑term safety in patients with moderate to severe disease.
- Induction of clinical remission
- Long‑term safety and tolerability
- Moderate to severe ulcerative colitis population
The program seeks to enhance therapeutic options for individuals suffering from inflammatory bowel disease, aiming to provide more effective and safer treatment pathways.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Amgen Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Oleg Tyszkiwski CENTRUM GASTROLOGICZNE GORCZYN OLEG TYSZKIWSKI
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Efavaleukin Alfa for Induction Therapy in Moderately to Severely Active Ulcerative Colitis: A Phase 2 Randomized, Double-blind, Placebo-controlled Study | Amgen Inc. | Phase II | Not Recruiting | Mar 2022 | Aug 2024 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.